Wilson’s Disease: A Comprehensive Review of the Molecular Mechanisms

@article{Wu2015WilsonsDA,
  title={Wilson’s Disease: A Comprehensive Review of the Molecular Mechanisms},
  author={Fei Wu and Jing Wang and Chunwen Pu and Liang Qiao and Chunmeng Jiang},
  journal={International Journal of Molecular Sciences},
  year={2015},
  volume={16},
  pages={6419 - 6431}
}
Wilson’s disease (WD), also known as hepatolenticular degeneration, is an autosomal recessive inherited disorder resulting from abnormal copper metabolism. Reduced copper excretion causes an excessive deposition of the copper in many organs such as the liver, central nervous system (CNS), cornea, kidney, joints, and cardiac muscle where the physiological functions of the affected organs are impaired. The underlying molecular mechanisms for WD have been extensively studied. It is now believed… 

Figures from this paper

Pathogenesis of Wilson disease.
New Therapeutic Perspectives for the Most Frequent ATP7B Mutation in Wilson Disease: Development of Pharmacologically Active Peptides and Generation of a Novel WD Isogenic Cell Model
TLDR
Evidence that residual Cu transport activity is retained by ATP7B-H1069Q and that correcting agents can indeed localize this mutant to the Golgi complex has spurred great interest in investigating the potentially therapeutic implications of these findings.
The genetics of Wilson disease.
Mutation Analysis of the ATP7B Gene in Seven Chinese Families with Wilson’s Disease
TLDR
Genetic defects of 7 Han Chinese families with Wilson’s disease are revealed, and has implications for their genetic counseling and clinical management.
Metal Toxicity and Brain-Liver Axis
TLDR
This chapter will focus on the crucial importance of relationship between liver and brain functioning and on the effects produced when this relationship is compromised and the role that toxic metals play on neurological symptoms in such disorders.
WilsonGen a comprehensive clinically annotated genomic variant resource for Wilson’s Disease
TLDR
A comprehensive resource of genetic variants in ATP7B gene manually curated from literature and data resources and systematically annotated using the ACMG & AMP guidelines for assessing pathogenicity is described.
A case of Wilson disease with the ATP7B mutation presenting movement disorders
TLDR
An adolescent case with no family history presented with extrapyramidal dyskinesia with typical presentation of blood test results and brain MRI images helps to suspect Wilson disease.
Wilson's disease patient with iron metabolism discharge barriers: A case report.
TLDR
The present case demonstrates that the SWI hyperintense area in the bilateral lenticular nuclei, substantia nigra and red nucleus combined with the patient's symptoms indicated that there is a possibility to diagnose WD when it is not detected by genetic analysis.
Characterization of Fibrinogen as a Key Modulator in Patients with Wilson’s Diseases with Functional Proteomic Tools
TLDR
The liver injury or oxidative stress induced by the progression of WD may account for the obvious increase of fibrinogen, which in turn triggers inflammatory responses and interferes coagulation cascades; this finding sheds light on the early detection and diagnosis of WD.
Targeting Higher Levels of Tau Protein in Ukrainian Patients with Wilson’s Disease
TLDR
This study provides novel data revealing that high tau protein levels in Wilson's disease patients could be a potential biomarker for axonal impairment and possible neuronal damage due to tauprotein, leading to neurodegeneration in WD.
...
...

References

SHOWING 1-10 OF 89 REFERENCES
The Treatment of Wilson's Disease, a Rare Genetic Disorder of Copper Metabolism
TLDR
Five drugs are currently available to treat Wilson's disease: British Anti-Lewisite; D-penicillamine; trientine; zinc sulfate or acetate; zinc chloride; and ammonium tetrathiomolybdate, which can reduce copper levels and/or transform copper into a metabolically inert and unavailable form in the patient.
Systems biology approach to Wilson’s disease
TLDR
A systems biology approach promises to generate a comprehensive view of Wilson's disease onset and progression, thus helping with a more fine-tune treatment and monitoring of the disorder.
Clinical molecular diagnosis of Wilson disease.
TLDR
Although hepatic copper concentration has been the gold standard for diagnosis, direct sequencing of the ATP7B gene is sensitive, specific, and can obviate the need for invasive liver biopsy, which should be standard practice in the diagnosis of Wilson disease.
A genetic study of Wilson's disease: evidence for heterogeneity.
TLDR
Findings suggest that defective synthesis of ceruloplasmin is a rather fundamental manifestation of the disease, and patients and to a lesser degree heterozygotes show an increased total body retention of copper.
Molecular mechanism of copper transport in Wilson disease.
TLDR
Results suggest that the core determines the metal ion specificity of P-type ATPases, and the N-terminal metal-binding domain may play a regulatory role.
Structural and metabolic changes in Atp7b−/− mouse liver and potential for new interventions in Wilson's disease
  • D. Huster
  • Biology, Chemistry
    Annals of the New York Academy of Sciences
  • 2014
TLDR
Mouse models have revealed new insights into pathomechanisms of hepatic WD andGene expression studies using microarrays have aided understanding of the molecular basis of these changes, which may facilitate the development of specific therapies to ameliorate WD progression.
Advance in the pathogenesis and treatment of Wilson disease
TLDR
Treatment for Wilson disease includes chelation of excessive copper accumulation and reduction of copper intake, and Liver transplantation is especially helpful for patients who fail to respond to medical therapy or present with fulminant liver failure.
Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease.
TLDR
It is suggested that the mitochondrion constitutes a pivotal target of copper in Wilson disease, and copper-chelating agents reversed mitochondrial accumulation of copper, as well as signs of intra-mitochondrial membrane crosslinking, thereby preserving the functional and structural integrity of mitochondria.
The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene
TLDR
The predicted functional properties of the pWD gene together with its strong homology to Mc1, genetic mapping data and identification of four independent disease–specific mutations, provide convincing evidence that pWD is the Wilson disease gene.
Cell therapy to remove excess copper in Wilson's disease
  • Sanjeev Gupta
  • Medicine, Biology
    Annals of the New York Academy of Sciences
  • 2014
TLDR
Cell therapy studies in animal models elicited major differences in the mechanisms driving liver repopulation with transplanted hepatocytes in Wilson's disease versus nondiseased settings, and noninvasive imaging was developed to demonstrate Cu removal from the liver, including after cell therapy inWilson's disease.
...
...